Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,248
datasets available to search
ShareScore release 0.9.0
Dataset results
2,248 results for “squamous cell carcinoma”
Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06288191. IPD Sharing: NO. Countries: 1. Publications: 0.
The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06241066. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07244978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus
ClinicalTrials.gov study NCT00766480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07312578. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06728618. IPD Sharing: NO. Countries: 1. Publications: 0.
Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05007613. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05947201. IPD Sharing: NO. Countries: 1. Publications: 0.
SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04937972. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung
ClinicalTrials.gov study NCT03321747. IPD Sharing: NO. Countries: 1. Publications: 0.
Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06412419. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07079410. IPD Sharing: NO. Countries: 1. Publications: 0.
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05913388. IPD Sharing: NO. Countries: 1. Publications: 0.
Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With
ClinicalTrials.gov study NCT06869473. IPD Sharing: NO. Countries: 1. Publications: 0.
Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06563869. IPD Sharing: NO. Countries: 1. Publications: 0.
Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope
ClinicalTrials.gov study NCT03069846. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
ClinicalTrials.gov study NCT07136545. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
ClinicalTrials.gov study NCT02139020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06857279. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04603248. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.